G702-4364 Screening compound: N-[2-(2-furyl)-6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl]-N-(2-thienylmethyl)amine

G702-4364 Screening compound: N-[2-(2-furyl)-6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl]-N-(2-thienylmethyl)amine
G702-4364 Screening compound: N-[2-(2-furyl)-6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl]-N-(2-thienylmethyl)amine alternative view

Chemical Structure Depiction of ChemDiv screening compound G702-4364
N-[2-(2-furyl)-6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl]-N-(2-thienylmethyl)amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G702-4364

Molecular Formula

C17H15N5OS (C17 H15 N5 OS)

Compound Name

N-[2-(2-furyl)-6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl]-N-(2-thienylmethyl)amine

IUPAC name

11-(furan-2-yl)-N-[(thiophen-2-yl)methyl]-181012-tetraazatricyclo[7.3.0.0^{37}]dodeca-27911-tetraen-2-amine

SMILES

C(c1cccs1)Nc1c(CCC2)c2nc2nc(-c3ccco3)nn12

InChI

InChI=1S/C17H15N5OS/c1-5-12-13(6-1)19-17-20-15(14-7-2-8-23-14)21-22(17)16(12)18-10-11-4-3-9-24-11/h2-4,7-9,18H,1,5-6,10H2

InChI Key

IZZSTJVRJLJDEQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27152049

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

337.41

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.984

Distribution Coefficient, logD

2.984

Water Solubility, LogSw

-3.20

Polar Surface Area

53.178

Acid Dissociation Constant (pKa)

14.56

Base Dissociation Constant (pKb)

0.24

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.50

G702-4364 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

C-Met Library (15277 compounds)

GPCR Targeted Library (31838 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G702-4364 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G702-4364?
Check Price and Availability of G702-4364, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G702-4364 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G702-4364
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G702-4364
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G702-4364 available by request